Machine Learning-Based SERS Chemical Space for Two-Way Prediction of Structures and Spectra of Untrained Molecules
Abstract
Identifying unknown molecules beyond existing databases remains challenging in surface-enhanced Raman scattering (SERS) spectroscopy. Conventional SERS analysis relies on matching experimental and cataloged spectra, limiting identification to known molecules in databases. With a vast chemical space of >1060 molecules, it is impractical to obtain the spectra of every molecule and rely solely on in silico techniques for spectral predictions. Here, we showcase an ML-based SERS chemical space that leverages key spectra-structure correlations to achieve two-way spectra-to-structure and structure-to-spectra predictions for untrained molecules with a >90% average accuracy. Using a SERS chemical space comprising 38 linear molecules from four classes (alcohols, aldehydes, amines, and carboxylic acids), our experimental and in silico studies reveal underlying spectral features that enable the prediction of untrained molecules represented by two molecular descriptors (functional group and carbon chain length). For forward spectra-to-structure predictions, we devise a two-step "classification and regression" ML framework to sequentially predict the functional group and carbon chain length of untrained molecules with 100% accuracy and ≤1 carbon difference, respectively. In addition, using an eXtreme Gradient Boosting (XGBoost) regressor trained on the two molecular descriptors, we attain inverse structure-to-spectra prediction with a high average cosine similarity of 90.4% between the…
How strong is the evidence?
Evidence Hub reads this as a experimental / empirical study, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.